02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 72.05
−1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 20.56x
- P/E 2027E
- —
- P/E 2028E
- 39.24x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.16x
- PEG TTM
- —
- Price / book
- 4.60x
- Price / sales
- 22.38x
- Price / cash flow
- -49.89x
Enterprise value
- Enterprise value
- HKD 18.5B
- EV / sales
- 19.29x
- EV / EBITDA
- -30.31x
- EV / EBIT
- -25.84x
- Market cap
- HKD 21.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026